Cited by 461Diabetes Management and ResearchHyperglycemia and glycemic control in critically ill and hospitalized patientsDiabetes Treatment and Management

Diabetic ketoacidosis

Open access
Dhatariya, Ketan K., Glaser, Nicole S., Codner, Ethel, Umpierrez, Guillermo E.·2020·Nature Reviews Disease Primers

Abstract

Diabetic ketoacidosis (DKA) is the most common acute hyperglycaemic emergency in people with diabetes mellitus. A diagnosis of DKA is confirmed when all of the three criteria are present - 'D', either elevated blood glucose levels or a family history of diabetes mellitus; 'K', the presence of high urinary or blood ketoacids; and 'A', a high anion gap metabolic acidosis. Early diagnosis and management are paramount to improve patient outcomes. The mainstays of treatment include restoration of circulating volume, insulin therapy, electrolyte replacement and treatment of any underlying precipitating event. Without optimal treatment, DKA remains a condition with appreciable, although largely preventable, morbidity and mortality. In this Primer, we discuss the epidemiology, pathogenesis, risk factors and diagnosis of DKA and provide practical recommendations for the management of DKA in adults and children.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41572-020-0165-1

Cites

261 of 262 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Acetoacetate and acetone may increase as beta-hydroxybutyrate falls during successful therapy of diabetic ketoacidosis.

    “since AcAc and acetone may increase as bOHB falls during successful therapy (295,298).”

    From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [298]

    The Diagnosis section (page unavailable) says β-hydroxybutyrate should decrease following fluid and intravenous insulin treatment. It discusses acetoacetate testing but does not say acetoacetate increases during successful therapy, and the searched passages do not report an increase in acetone. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • The two major mechanisms responsible for the high ketone concentrations in people with diabetes are increased production from triglycerides and decreased utilization in the liver, both a result of absolute or relative insulin deficiency and increased counterregulatory hormones including cortisol, epinephrine, glucagon, and growth hormone.

    “The two major mechanisms responsible for the high ketone concentrations in people with diabetes are increased production from triglycerides and decreased utilization in the liver, both a result of absolute or relative insulin deficiency and increased counterregulatory hormones including cortisol, epinephrine, glucagon, and growth hormone (298).”

    From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [298]

    Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured
  • Blood ketone determinations that measure beta-hydroxybutyrate specifically are useful for both diagnosis and ongoing monitoring of diabetic ketoacidosis.

    “Blood ketone determinations that measure bOHB specifically are useful for both diagnosis (299,301) and ongoing monitoring of DKA (298,299).”
  • Beta-hydroxybutyrate is the predominant ketone body in diabetic ketoacidosis.

    “bOHB, the predominant ketone body in DKA, is not detected.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [42]42. Otieno,C.F., Kayima,J.K., Omonge,E.O. & Oyoo,G.O. Diabetic ketoacidosis: risk factors, mechanisms and management strategies in sub-Saharan Africa: a review. E. Afr. Med. J 82, S197-203 (2005).

Cited by

Sorted by citations

Authors
Dhatariya, K. K., Glaser, N. S., Codner, E., & Umpierrez, G. E.
Affiliations
  • University of East Anglia (GB)
  • University of California, Davis (US)
  • Emory University (US)
Corresponding author
Umpierrez, Guillermo E.
Venue
Nature Reviews Disease Primers
Published
2020-05-14
Volume
6
Issue
1
Pages
40-40
ISSN
2056-676X (ISSN-L)
OpenAlex
W4211168619
Cited by
461
References
262
Citations by year
2026: 80 · 2025: 104 · 2024: 92 · 2023: 71 · 2022: 63 · 2021: 44 · 2020: 6
FWCI
7.10
Type
journal article
Language
en
Open access
Locations
  • Nature Reviews Disease Primers (publishedVersion)
  • PubMed (publishedVersion)
  • UEA Digital Repository (University of East Anglia) (submittedVersion)
  • Universidad de Chile (submittedVersion, cc-by-nc-nd)
Funders
  • American Diabetes Association (1-17-IBS-186)
  • Sanofi
  • Emory University
  • Dexcom
  • Novo Nordisk
  • Fondo Nacional de Ciencia y Tecnología
  • National Institutes of Health (P30DK11102, UL1TR002378)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK11102, P30DK111024)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
diabetic ketoacidosis, diabetes mellitus, anion gap metabolic acidosis, ketone bodies, insulin therapy, fluid resuscitation, electrolyte replacement, pathogenesis, risk factors, diagnosis, recurrence prevention, children
MeSH terms
Acidosis, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Fluid Therapy, Humans, Hypoglycemic Agents, Insulin, Risk Factors, Diabetic Ketoacidosis, Disease Management

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review